Literature DB >> 15143471

Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.

Juan I Arenas1, Juan F Gallegos-Orozco, Tomasz Laskus, Jeff Wilkinson, Amer Khatib, Carlos Fasola, Debra Adair, Marek Radkowski, Karen V Kibler, Marek Nowicki, David Douglas, James Williams, George Netto, David Mulligan, Goran Klintmalm, Jorge Rakela, Hugo E Vargas.   

Abstract

BACKGROUND: The dynamics of hepatitis C virus (HCV) quasi species in the E2 region may correlate with the course of infection after orthotopic liver transplantation (OLT).
METHODS: Thirty-four patients who underwent transplantation for HCV-related cirrhosis were studied. Serum and liver samples were available before OLT and at 1 week, 4 months, and 1 year after OLT. Patients were divided into group 1 (Knodell/Ishak fibrosis stage [FS] at 1 year, <2) and group 2 (FS at 1 year, > or =2). Complexity was estimated by the number of bands in a single-strand conformational polymorphism assay, whereas diversity was measured by Shannon entropy (SE) and median mobility shift (MMS) values derived from the heteroduplex mobility assay. Diversity dynamics were measured at transmission (before OLT vs. 1 week after OLT) and after OLT (1 week after OLT vs. 1 year after OLT).
RESULTS: Complexity was higher in group 1 patients than in group 2 patients before OLT (P<.02) and at 1 week after OLT (P<.04). Diversity decreased in group 1 at transmission, as measured by either SE (P<.01) or MMS (P<.04). However, diversity increased in this group after OLT, as measured by SE (P<.03) or MMS (P<.02). FS at 1 year after OLT correlated with transmission changes, as measured by SE (r=0.642, P<.0001) and MMS (r=0.443, P<.04), and with post-OLT changes (for SE: r=-0.583, P<.01; for MMS: r=-0.536, P<.01).
CONCLUSIONS: HCV complexity and diversity in the E2 region correlated with the severity of recurrence of HCV infection after OLT. Increased diversity of quasi species at transmission correlated with a higher FS at 1 year. However, increased diversity of quasi species in the post-OLT period correlated with a lower FS at 1 year. The dynamics of HCV quasi species in patients who undergo transplantation are predictive of outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143471     DOI: 10.1086/386338

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Unexpected maintenance of hepatitis C viral diversity following liver transplantation.

Authors:  Rebecca R Gray; Samantha L Strickland; Nazle M Veras; Maureen M Goodenow; Oliver G Pybus; Stanley M Lemon; Michael W Fried; David R Nelson; Marco Salemi
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  HCV in liver transplantation.

Authors:  Giacomo Germani; Emmanuel Tsochatzis; Vasilios Papastergiou; Andrew K Burroughs
Journal:  Semin Immunopathol       Date:  2012-07-25       Impact factor: 9.623

4.  Wide range of quasispecies diversity during primary hepatitis C virus infection.

Authors:  Belinda L Herring; Rose Tsui; Lorraine Peddada; Michael Busch; Eric L Delwart
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 5.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

6.  Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.

Authors:  Benjamin G Vincent; Ellen F Young; Adam S Buntzman; Rosemary Stevens; Thomas B Kepler; Roland M Tisch; Jeffrey A Frelinger; Paul R Hess
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

7.  Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.

Authors:  Bing-Shui Xiu; Xiao-Yan Feng; Jing He; Guo-Hua Wang; Xiang-Ying Zhang; He-Qiu Zhang; Xiao-Guo Song; Kun Chen; Shi-Gan Ling; Cui-Xia Zhu; Lai Wei; Hui-Ying Rao
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

8.  Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.

Authors:  Hui Li; Brian J McMahon; Susan McArdle; Dana Bruden; Daniel G Sullivan; Dave Shelton; Heike Deubner; David R Gretch
Journal:  Virology       Date:  2008-03-17       Impact factor: 3.616

9.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

Review 10.  The epidemiology of hepatitis C infection in the United States.

Authors:  Vinod K Rustgi
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.